Pharma Stocks
-
Johnson & Johnson (JNJ) Stock Could Be 7.3% Undervalued Based On Its Pharma And MedTech Focus
Johnson & Johnson (JNJ) is back in focus after recent share price weakness, with the stock down 2% over the…
Read More » -
If I Had to Start Over With $1,000 in Stocks Today, Here’s Exactly What I’d Buy
It’s never too late to start investing. Whether the market is rising or falling, you’ll always find opportunities to buy…
Read More » -
3 Stocks That Could Benefit From the GLP-1 Boom: TDOC, OLLI, DXCM
The GLP-1 revolution is quietly continuing even as investor interest has moved on to more timely topics. One of the…
Read More » -
How Strong Quarterly Results and MERGE Partnership Will Impact Supernus Pharmaceuticals (SUPN) Investors
Supernus Pharmaceuticals recently reported strong year-over-year growth in quarterly revenue and net profit, while also expanding its partnership with MERGE,…
Read More » -
Aurobindo Pharma subsidiary Eugia Steriles faces five US FDA observations
Drug maker Aurobindo Pharma Ltd on Friday (June 19) said the United States Food and Drug Administration (US FDA) has…
Read More » -
UCB Stock – Weekly review and pharma peer comparison
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 15:43 CET. Details in the…
Read More » -
How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story
While investors fixate on the pipeline, a powerful and accelerating profit stream from its Sanofi collaboration is quietly reshaping the…
Read More » -
LongBio Pharma (Suzhou) (SEHK:1779) Stock Looks Rich With A 65.1x P B Multiple
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.…
Read More » -
Why Healthcare Value Stocks Are Back on The Radar?
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum
Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price…
Read More »
